Home › Small Cell Lung Cancer › Maryland › Baltimore
Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Baltimore, MD
Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Baltimore. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Nagre-recruitPhase 3
- University of Maryland School of Medicine, Baltimore
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Nagre-recruitPhase 1/2
- United Theranostics, Glen Burnie · 9 mi ang layo
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Nagre-recruitPhase 2
- University of Maryland, Baltimore
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Nagre-recruitPhase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Nagre-recruitPhase 3
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
- John Hopkins School of Medicine, Baltimore
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Nagre-recruitPhase 2
- University of Maryland School of Medicine, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Nagre-recruitPhase 1/2
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Nagre-recruitObservasyonal na pag-aaral
- Johns Hopkins University, Baltimore
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Nagre-recruitPhase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Nagre-recruitPhase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod
- Houston, TX26 pag-aaral
- Arlington, VA23 pag-aaral
- New York City, NY22 pag-aaral
- Boston, MA21 pag-aaral
- Nashville, TN20 pag-aaral
- Los Angeles, CA20 pag-aaral
- Orlando, FL15 pag-aaral
- Dallas, TX13 pag-aaral
- Cleveland, OH13 pag-aaral
- Chicago, IL13 pag-aaral
- St. Louis, MO13 pag-aaral
- Detroit, MI12 pag-aaral
Iba pang pag-aaral sa Baltimore
- Non-Small Cell Lung Cancer60 pag-aaral
- Kanser sa Suso47 pag-aaral
- Kanser sa Prostate43 pag-aaral
- Kanser sa Baga40 pag-aaral
- Kanser (lahat ng uri)37 pag-aaral
- Kanser sa Pancreas31 pag-aaral
- Colorectal Cancer31 pag-aaral
- Metastatic Cancer28 pag-aaral
- Obesity26 pag-aaral
- Kanser sa Pantog24 pag-aaral
- Pagkabigo ng Puso24 pag-aaral
- Kanser sa Ovary22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.